GSK-2018682 Uses, Dosage, Side Effects and more
GSK2018682 has been investigated for the treatment of Multiple Sclerosis, Relapsing-Remitting.
| Attribute | Details |
|---|---|
| Trade Name | GSK-2018682 |
| Generic | GSK-2018682 |
| Type | |
| Formula | C22H21ClN4O4 |
| Weight | Average: 440.88 Monoisotopic: 440.1251329 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
